# Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction

> **NCT02672566** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 82 (actual)

## Conditions studied

- Fetal Growth Retardation

## Interventions

- **DRUG:** Enoxaparin
- **OTHER:** Usual care

## Key facts

- **NCT ID:** NCT02672566
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-22
- **Primary completion:** 2019-09-05
- **Final completion:** 2020-01-22
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2020-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02672566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02672566, "Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02672566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*